4.07
-0.15 (-3.55%)
| Penutupan Terdahulu | 4.22 |
| Buka | 4.18 |
| Jumlah Dagangan | 841,034 |
| Purata Dagangan (3B) | 3,528,122 |
| Modal Pasaran | 463,709,120 |
| Harga / Buku (P/B) | 2.45 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 May 2026 |
| Margin Operasi (TTM) | -6,383.63% |
| EPS Cair (TTM) | -1.23 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.34% |
| Nisbah Semasa (MRQ) | 17.02 |
| Aliran Tunai Operasi (OCF TTM) | -53.72 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -87.14 M |
| Pulangan Atas Aset (ROA TTM) | -15.56% |
| Pulangan Atas Ekuiti (ROE TTM) | -32.92% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Perspective Therapeutics, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.63 |
|
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| % Dimiliki oleh Orang Dalam | 18.83% |
| % Dimiliki oleh Institusi | 61.12% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Avidity Partners Management Lp | 31 Dec 2025 | 3,210,733 |
| Nicholson Wealth Management Group, Llc | 31 Dec 2025 | 1,617,993 |
| Opaleye Management Inc. | 31 Dec 2025 | 1,184,500 |
| Patient Square Capital Lp | 31 Dec 2025 | 1,132,815 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |